Search

Your search keyword '"Nilforooshan, Ramin"' showing total 277 results

Search Constraints

Start Over You searched for: Author "Nilforooshan, Ramin" Remove constraint Author: "Nilforooshan, Ramin"
277 results on '"Nilforooshan, Ramin"'

Search Results

1. Evaluating Spoken Language as a Biomarker for Automated Screening of Cognitive Impairment

2. Binocular Vision, Visual Function, and Pupil Dynamics in People Living With Dementia and Their Relation to the Rate of Cognitive Decline and Structural Changes Within the Brain: Protocol for an Observational Study

6. A Markov Chain Model for Identifying Changes in Daily Activity Patterns of People Living with Dementia

8. Designing A Clinically Applicable Deep Recurrent Model to Identify Neuropsychiatric Symptoms in People Living with Dementia Using In-Home Monitoring Data

9. Semi-supervised Learning for Identifying the Likelihood of Agitation in People with Dementia

10. An Intelligent Bed Sensor System for Non-Contact Respiratory Rate Monitoring

11. An attention model to analyse the risk of agitation and urinary tract infections in people with dementia

12. Deep Representation for Connected Health: Semi-supervised Learning for Analysing the Risk of Urinary Tract Infections in People with Dementia

14. Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)

16. Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

17. Quantification of neurofilament light and glial fibrillary acidic protein in finger-prick blood

18. Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?

21. Dysfunctional cerebral glucose transport in Alzheimer’s Disease

22. MRI CHANGES FOLLOWING TREATMENT OF GLP‐1 ANALOGUE, LIRAGLUTIDE IN ALZHEIMER’S DISEASE

24. Magnetic Resonance Spectroscopy metabolites as biomarkers of Alzheimer’s Disease

26. Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial

27. A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial

28. Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

29. A Protocol for Evaluating Digital Technology for Monitoring Sleep and Circadian Rhythms in Older People and People Living with Dementia in the Community.

31. Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

32. Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations

33. Remote Monitoring of Physiology in People Living With Dementia: An Observational Cohort Study

36. Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)

38. A pragmatic, multicentre, double-blind, placebocontrolled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.

41. Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial

44. Study of mirtazapine for agitated behaviours in dementia (SYMBAD): A randomised, 1 double-blind, placebo-controlled trial

50. Additional file 2 of Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?

Catalog

Books, media, physical & digital resources